Conatus Pharmaceuticals Inc. (CNAT)
(Delayed Data from NSDQ)
$0.90 USD
+0.05 (5.88%)
Updated May 3, 2019 03:59 PM ET
After-Market: $0.90 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
Histogen Inc. [CNAT]
Reports for Purchase
Showing records 1 - 20 ( 226 total )
Company: Histogen Inc.
Industry: Medical - Products
Search for a Strategic Exit Continues; Dropping Coverage
Provider: H.C. Wainwright & Co., Inc.
Analyst: ARCE E
Company: Histogen Inc.
Industry: Medical - Products
Emricasan Partnership Formally Ends While Strategic Alternative Search Continues
Provider: H.C. Wainwright & Co., Inc.
Analyst: ARCE E
Company: Histogen Inc.
Industry: Medical - Products
Healthcare - Accelerating the Pace: Perspectives From Our 3rd Annual NASH Investor Conference
Provider: H.C. Wainwright & Co., Inc.
Analyst: ARCE E
Company: Histogen Inc.
Industry: Medical - Products
Company: Histogen Inc.
Industry: Medical - Products
Operations on Hiatus While Seeking Strategic Alternatives
Provider: H.C. Wainwright & Co., Inc.
Analyst: ARCE E
Company: Histogen Inc.
Industry: Medical - Products
Company: Histogen Inc.
Industry: Medical - Products
Winding Down Emricasan; Seeking Strategic Options; Remove PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: ARCE E
Company: Histogen Inc.
Industry: Medical - Products
Company: Histogen Inc.
Industry: Medical - Products
Company: Histogen Inc.
Industry: Medical - Products
Company: Histogen Inc.
Industry: Medical - Products
Company: Histogen Inc.
Industry: Medical - Products
Company: Histogen Inc.
Industry: Medical - Products
Healthcare -Recap of 34 Notes From Our Coverage of EASL 2019 and AASLD
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Histogen Inc.
Industry: Medical - Products
Recap of 22 Expert Calls in 2018 - 2019 for Our Coverage Universe
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Histogen Inc.
Industry: Medical - Products
Expecting Additional Data Readouts in 2019 to Determine Emricasan''s Future; Maintain Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: ARCE E
Company: Histogen Inc.
Industry: Medical - Products
Company: Histogen Inc.
Industry: Medical - Products
Healthcare - Walk Through Yas'' Shoes at EASL - Our EASL Roadmap
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Histogen Inc.
Industry: Medical - Products
Healthcare - Part 2: Digging Through ICPT EASL Abstracts
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Histogen Inc.
Industry: Medical - Products
Company: Histogen Inc.
Industry: Medical - Products
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.